Company profile ICAD

Icad Inc
icad is a leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. icad offers a comprehensive range of high-performance, upgradeable cad solutions for mammography and advanced image analysis and workflow solutions for magnetic resonance imaging, for breast and prostate cancers and comp...uted tomography for colorectal cancer. icad’s xoft system, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. the xoft system is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer. for more information, call 877-icadnow, or visit www.icadmed.com. Show More
Quarter analysis & expected interestLast update: February 09 2024 17:46:28.

After 39 days of this quarter the interest is at 315.0. Based on that we can calculate that during remaining 52 days it will total up to 735.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019404
603
49.3% QoQ
613
1.7% QoQ
672
9.6% QoQ
2020 624
54.5% YoY -7.1% QoQ
478
-20.7% YoY -23.4% QoQ
519
-15.3% YoY 8.6% QoQ
514
-23.5% YoY -1.0% QoQ
2021 505
-19.1% YoY -1.8% QoQ
501
4.8% YoY -0.8% QoQ
451
-13.1% YoY -10.0% QoQ
573
11.5% YoY 27.1% QoQ
2022 599
18.6% YoY 4.5% QoQ
697
39.1% YoY 16.4% QoQ
606
34.4% YoY -13.1% QoQ
762
33.0% YoY 25.7% QoQ
2023 769
28.4% YoY 0.9% QoQ
833
19.5% YoY 8.3% QoQ
709
17.0% YoY -14.9% QoQ
886
16.3% YoY 25.0% QoQ
2024 315
-59.0% YoY -64.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and cancer detection search interestLast update: February 09 2024 17:46:27.
Correlation coefficient between keyword and revenue is -0.56
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 17:46:28.

The average 5 years interest of cancer detection was 48.4 per week.
The last year interest of cancer detection compared to the last 5 years has changed by 26.82%.
The interest for cancer detection is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 25.86%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 17:46:32.

After 39 days of this quarter the interest is at 443.0. Based on that we can calculate that during remaining 52 days it will total up to 1034.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019611
976
59.7% QoQ
853
-12.6% QoQ
880
3.2% QoQ
2020 924
51.2% YoY 5.0% QoQ
758
-22.3% YoY -18.0% QoQ
808
-5.3% YoY 6.6% QoQ
768
-12.7% YoY -5.0% QoQ
2021 810
-12.3% YoY 5.5% QoQ
860
13.5% YoY 6.2% QoQ
841
4.1% YoY -2.2% QoQ
883
15.0% YoY 5.0% QoQ
2022 1008
24.4% YoY 14.2% QoQ
1005
16.9% YoY -0.3% QoQ
929
10.5% YoY -7.6% QoQ
1005
13.8% YoY 8.2% QoQ
2023 1152
14.3% YoY 14.6% QoQ
1096
9.1% YoY -4.9% QoQ
1006
8.3% YoY -8.2% QoQ
1131
12.5% YoY 12.4% QoQ
2024 443
-61.5% YoY -60.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and cancer therapy search interestLast update: February 09 2024 17:46:32.
Correlation coefficient between keyword and revenue is -0.88
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 17:46:33.

The average 5 years interest of cancer therapy was 71.83 per week.
The last year interest of cancer therapy compared to the last 5 years has changed by 15.63%.
The interest for cancer therapy is relatively stable and increasing in the last 5 years.
The last year interest is quite higher compared to 5 years ago. It has increased by 16.67%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for iCAD mammography to provide analysis

Correlation between past revenue and iCAD mammography search interest

There is not enough data for iCAD mammography to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for iCAD mammography to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for iCAD breast cancer to provide analysis

Correlation between past revenue and iCAD breast cancer search interest

There is not enough data for iCAD breast cancer to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for iCAD breast cancer to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for iCAD AI solutions to provide analysis

Correlation between past revenue and iCAD AI solutions search interest

There is not enough data for iCAD AI solutions to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for iCAD AI solutions to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for iCAD PowerLook to provide analysis

Correlation between past revenue and iCAD PowerLook search interest

There is not enough data for iCAD PowerLook to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for iCAD PowerLook to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for iCAD ProFound AI to provide analysis

Correlation between past revenue and iCAD ProFound AI search interest

There is not enough data for iCAD ProFound AI to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for iCAD ProFound AI to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for iCAD Xoft Axxent to provide analysis

Correlation between past revenue and iCAD Xoft Axxent search interest

There is not enough data for iCAD Xoft Axxent to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for iCAD Xoft Axxent to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for iCAD electronic brachytherapy to provide analysis

Correlation between past revenue and iCAD electronic brachytherapy search interest

There is not enough data for iCAD electronic brachytherapy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for iCAD electronic brachytherapy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ICAD
Earnings date: 2024-03-26 After close
Company name: Icad Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-10-21T12:28:00Z

BusinessWire
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy

2025-07-28T16:32:12-04:00

SEC
15-12G Form - Securities registration termination [Section 12(g)] - ICAD INC (0000749660) (Filer)

2025-07-22T00:15:14-04:00

SEC
EFFECT Form - Notice of Effectiveness - ICAD INC (0000749660) (Filer)

2025-07-22T00:15:13-04:00

SEC
EFFECT Form - Notice of Effectiveness - ICAD INC (0000749660) (Filer)

2025-07-22T00:15:12-04:00

SEC
EFFECT Form - Notice of Effectiveness - ICAD INC (0000749660) (Filer)

2025-07-22T00:15:10-04:00

SEC
EFFECT Form - Notice of Effectiveness - ICAD INC (0000749660) (Filer)

2025-07-22T00:15:09-04:00

SEC
EFFECT Form - Notice of Effectiveness - ICAD INC (0000749660) (Filer)

2025-07-22T00:15:08-04:00

SEC
EFFECT Form - Notice of Effectiveness - ICAD INC (0000749660) (Filer)

2025-07-22T00:15:06-04:00

SEC
EFFECT Form - Notice of Effectiveness - ICAD INC (0000749660) (Filer)

2025-07-22T00:15:05-04:00

SEC
EFFECT Form - Notice of Effectiveness - ICAD INC (0000749660) (Filer)

2025-07-22T00:15:04-04:00

SEC
EFFECT Form - Notice of Effectiveness - ICAD INC (0000749660) (Filer)

2025-07-22T00:15:02-04:00

SEC
EFFECT Form - Notice of Effectiveness - ICAD INC (0000749660) (Filer)

2025-07-17T13:00:00Z

GlobeNewswire
RadNet's Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD

2025-07-08T12:00:00Z

GlobeNewswire
iCAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote "FOR" Proposed Acquisition by RadNet, Inc.

2025-06-16T08:19:12-04:00

SEC
425 Form - Prospectuses and communications, business combinations - ICAD INC (0000749660) (Subject)